Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Friedreich’s Ataxia Therapy News

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

DNDStocks

Rank: Treasurer [?]

Points: 568 [?]

Votes: 13 Score: 2.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Friedreich’s Ataxia Therapy News - Very interesting

in response to

Re: Friedreich’s Ataxia Therapy News - Very interesting

Toinv

posted on May 26, 2017 11:44AM

Toinv said "....Pfizer has studied this molecule and is curious enough to conduct their own clinical trial"

Toinv, what clinical trial is pfizer conducting/planning with RVX208.

I must have missed something. This is fascinating news. Please share the details or point me to the link.